
Please try another search
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. The company was founded in 2002 and is based in Heze City, China.
Name | Age | Since | Title |
---|---|---|---|
Qi Mi | 34 | - | Chairman |
Xu Sheng Kong | 63 | - | Director |
Chao Chao Liu | 39 | - | Supervisor |
Li Kang | 51 | 2023 | Independent Director |
Qi Ming Zhang | 64 | 2020 | Independent Director |
Wen Xia Zhang | 40 | 2020 | Chairman of the Supervisory Board |
Lu Li | 48 | 2019 | Deputy GM, Board Secretary & Director |
Ya Ping Ma | 51 | - | Director |
Peng Fei Tu | 61 | - | Independent Director |
Yingying Zhang | 36 | 2023 | Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review